Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Biomark Capital
Lilly hopes to address immunology and pain indications with biotech’s LYTAC technology. Sunovion licenses European rights to Parkinson’s therapy Kynmobi to Bial.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
Philanthropist Ted Stanley made a multi-year $650m commitment to fund genomic research at the Eli and Edythe L Broad Institute in collaboration with scientists around the world that may generate biological pathways and molecules that could reignite pharmaceutical company interest in schizophrenia, bipolar disorder and other psychiatric conditions.
- Medical Devices
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Other Names / Subsidiaries
- Better Doctor
- HyperMEd Imaging
- Opus Bio
- Strand Life Sciences
- WhiteGlove Health